ERBB2 and breast cancer: We could not clarify the reason for false-positive fluorescence; however, it is supposed that this fluorescent method can be applied universally to breast cancer and its various subtypes, because gGlu-HMRG fluorescence is not correlated with the expression of the estrogen, progesterone or human epidermal growth factor 2 receptors.